The Global EGFR Testing Market Size Was Worth Around USD 2.15 Billion In 2024 And Is Predicted To Grow To Around USD 4.58 Billion By 2035 With A Compound Annual Growth Rate (CAGR) Of 7.12 % From 2025 To 2035.
The eGFR (estimated glomerular filtration rate) testing market comprises the overall global industry, providing means for diagnosing renal function through analysis of the way glomeruli filter blood. eGFR testing is an essential diagnostic tool that provides a means of identifying patients at risk of developing chronic kidney disease (CKD), diabetes, hypertension, and many other conditions affecting renal health. The eGFR testing market includes laboratory-based eGFR tests, point-of-care eGFR tests, and automated analysers used for eGFR testing in hospitals, clinics, and diagnostic centres. Major drivers of growth in this space include an increasing prevalence of CKD, a growing awareness of the importance of early detection, and continued advancements in technology available for testing.
This comprehensive market research report provides an in-depth analysis of the EGFR Testing market, with a focused evaluation of industry developments through 2025. The study delivers detailed insights into current market dynamics, emerging trends, growth drivers, competitive landscape, future strategic outlook, and the evolving regulatory key segments.
The Global EGFR Testing Market Report identifies emerging business opportunities while supporting informed strategic and tactical decision-making. Designed for stakeholders operating in a highly competitive and rapidly evolving landscape, this study delivers up-to-date market intelligence essential for tracking performance, mitigating risks, and driving sustainable growth and profitability.
Our expert team is consistently working on updated data and information on the key player's related business processes that value the market for future strategies and predictions
Get Access to a Free Copy of Our Latest Sample Report - https://www.decisionsadvisors.com/request-sample/4342
Market Segmentation:
By Product Type
- Kits
- Reagents
- Instruments
By Test Type
- Creatinine-based
- Cystatin C-based
- Combined
Key Players Detail:
In-depth competitive benchmarking analysis of the EGFR Testing Market, covering company market share, innovation strategies, product development, geographic expansion, and strategic partnerships shaping the industry landscape.
- Abbott Laboratories
- ARKRAY, Inc.
- Beckman Coulter, Inc.
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- DiaSys Diagnostic Systems GmbH
- F. Hoffmann-La Roche Ltd
- FUJIFILM Wako Pure Chemical Corporation
- Nova Biomedical
- Pointe Scientific, Inc.
- Randox Laboratories Ltd.
- Siemens Healthineers
- Sysmex Corporation
- Thermo Fisher Scientific Inc.
- Others
Key Insights Covered in the Global EGFR Testing Market Size & Industry Forecast Report (2020–2035):
1. Detailed analysis of the Global EGFR Testing Market Size, production capacity, utilization rate, output trends, capital investment patterns, and regulatory landscape, along with comprehensive profiles of leading market players.
2. Thorough assessment of EGFR Testing Market Growth, revenue analysis, historical performance, and forward-looking projections across major regional markets.
3. In-depth EGFR Testing Industry Analysis covering competitive landscape, company market share, pricing trends, and future opportunity mapping.
4. Strategic evaluation of recent developments including mergers & acquisitions, partnerships, collaborations, joint ventures, geographic expansions, and product launches shaping the EGFR Testing Market Share.
5. Comprehensive value chain and supply chain analysis highlighting raw material sourcing, distribution channels, and end-user segmentation.
6. Regional regulatory framework assessment and policy impact analysis influencing the EGFR Testing Industry Forecast across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
7. Coverage of technological advancements, product innovations, R&D investments, automation trends, and digital transformation influencing long-term Global EGFR Testing Market Growth.
Buy this report now:- https://www.decisionsadvisors.com/checkout/select-licence?report_id=4342
Industry Developments:
In July 2025, the FDA granted accelerated approval to sunvozertinib (brand name ZEGFROVY) for adults with metastatic non-small cell lung cancer (NSCLC) harbouring EGFR exon 20 insertion mutations who have progressed after platinum-based chemotherapy. This marks the first targeted oral therapy specifically approved for this difficult-to-treat mutation.
In June 2025, Datroway (datopotamab deruxtecan-dlnk, also known as Dato-DXd) received FDA accelerated approval for adults with previously treated advanced EGFR-mutated non-small cell lung cancer (NSCLC). It is the first TROP2-directed therapy approved in the U.S. for lung cancer, specifically for patients who have already received EGFR-targeted therapy and platinum-based chemotherapy.
Regional Analysis for EGFR Testing Market:
✫ North America: (U.S., Canada, Mexico)
✫ Europe: (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
✫ Asia-Pacific: (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
✫ South America: (Colombia, Brazil, Argentina, Rest of South America)
✫ Middle East & Africa: (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Benefits of the Report:
⏩ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
⏩ Top-down and bottom-up approach for regional analysis
⏩ Porter’s five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.
⏩ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market
Insightful inquiry before buying:- https://www.decisionsadvisors.com/request-customization/4342
Frequently asked questions:
➥ What is the market size of the EGFR Testing market?
➥ What is the market growth rate of the EGFR Testing market?
➥ What are the EGFR Testing market opportunities and threats faced by the vendors in the global EGFR Testing Industry?
➥ Which application/end-user or product type may seek incremental growth prospects? What is the market share of each type and application?
➥ What focused approach and constraints are holding the EGFR Testing market?
➥ What are the different sales, marketing, and distribution channels in the global industry?
Unlock the full report now! @ https://www.decisionsadvisors.com/reports/egfr-testing-market
About the Decisions Advisors
Decisions Advisors is a comprehensive market research and consulting company that provides actionable insights based on data. We deal with businesses from various industries and deliver a market intelligence, competitive analysis, forecasting, and bespoke consulting. We also conduct bespoke consulting for our clients.
We provides well-supported advice and intelligence on how businesses can operate in a given market and succeed in achieving their goals.
Contact Us:
Company Name: Decision Advisors
Email: sales@sphericalinsights.com
Phone: +1 303 800 4326 (US)
